Metabolon’s New Liver Fibrosis, Kidney Function Discovery Panels Reveal Disease Mechanisms
Metabolon, a global provider in metabolomics solutions, announced the launch of its new Liver Fibrosis and Kidney Function Discovery Panels.
Read MorePosted by Andy Lundin | Oct 17, 2023 | Diagnostic Technologies, Kidney Disease |
Metabolon, a global provider in metabolomics solutions, announced the launch of its new Liver Fibrosis and Kidney Function Discovery Panels.
Read MorePosted by Andy Lundin | Oct 17, 2023 | Lab Automation, Transport & Shipping |
The elevator and overhead components of Roche’s CCM Vertical system are designed to help labs optimize space, productivity, and patient care.
Read MorePosted by Andy Lundin | Oct 16, 2023 | Immunoassay Reagents & test Kits |
Werfen announced 510(k) clearance of Aptiva Connective Tissue Disease (CTD) Essential reagent by the U.S. Food and Drug Administration (FDA).
Read MorePosted by Andy Lundin | Oct 16, 2023 | Prostate |
ArteraAI will present data demonstrating the successful validation of its prognostic model in advanced prostate cancer.
Read MorePosted by Andy Lundin | Oct 11, 2023 | Cancer, Digital Pathology |
CorePlus, a high complexity anatomic pathology laboratory, diagnosed over 10,000 cases using Ibex’s AI-powered cancer diagnostics platform.
Read More